Evidence map›Paper›PMID 42488731›Full record

ArticleCase reports in oncology

Primary Extragonadal Choriocarcinoma Presenting with Pneumothorax in an Elderly Male Patient: A Case Report.

Hiroshi Shintani, Naoki Kataoka

Abstract readCase Reports
In one paragraph

Article in Case reports in oncology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Hiroshi ShintaniDepartment of Surgery, Kishiwada Tokushukai Hospital, Osaka, Japan.
Naoki KataokaDepartment of Surgery, Kishiwada Tokushukai Hospital, Osaka, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Non-gestational choriocarcinoma is an extremely rare and highly aggressive trophoblastic malignancy in male patients. It frequently presents with multiorgan metastases and poor prognosis. Spontaneous pneumothorax associated with metastatic pulmonary tumors is uncommon and may indicate rapid tumor progression. Here, we report a rare case of primary extragonadal choriocarcinoma presenting with pneumothorax in an elderly male patient. Case Presentation: An 80-year-old man presented with cough and dyspnea. Chest computed tomography revealed right pneumothorax, more than 30 bilateral pulmonary nodules, mediastinal lymphadenopathy, and hepatic lesions. Persistent air leakage required thoracoscopic surgery. Histopathological examination of the resected lung specimen demonstrated hemorrhagic and necrotic nodules with biphasic trophoblastic morphology. Immunohistochemistry was positive for GATA binding protein 3, human chorionic gonadotropin, and CK7, leading to the diagnosis of choriocarcinoma. The serum human chorionic gonadotropin level was markedly elevated at 17,000 mIU/mL. Positron emission tomography/computed tomography revealed no abnormalities in the testes, and the tumor was considered most consistent with primary extragonadal choriocarcinoma. Despite temporary postoperative improvement, the disease progressed rapidly and the patient died on hospitalization day 24. Conclusion: This rare case highlights that choriocarcinoma should be considered in the differential diagnosis of pneumothorax accompanied by multiple pulmonary nodules, even in elderly male patients. Pneumothorax occurring before treatment may reflect highly aggressive tumor behavior, emphasizing the importance of early pathological diagnosis and prompt clinical intervention.

Indexed as

ElderlyMalePneumothoraxPrimary choriocarcinoma

Identifiers

PMID42488731
PMCPMC13391071

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.